37 related articles for article (PubMed ID: 38638156)
1. Genetic deletion of gpr27 alters acylcarnitine metabolism, insulin sensitivity, and glucose homeostasis in zebrafish.
Nath AK; Ma J; Chen ZZ; Li Z; Vitery MDC; Kelley ML; Peterson RT; Gerszten RE; Yeh JJ
FASEB J; 2020 Jan; 34(1):1546-1557. PubMed ID: 31914600
[TBL] [Abstract][Full Text] [Related]
2. Clinical impact of revisions to the WHO classification of diffuse gliomas and associated future problems.
Sonoda Y
Int J Clin Oncol; 2020 Jun; 25(6):1004-1009. PubMed ID: 32020379
[TBL] [Abstract][Full Text] [Related]
3. Input of molecular analysis in medical management of primary brain tumor patients.
Idbaih A; Duran-Peña A; Bonnet C; Ducray F
Rev Neurol (Paris); 2015; 171(6-7):457-65. PubMed ID: 26026669
[TBL] [Abstract][Full Text] [Related]
4. GPR27 expression correlates with prognosis and tumor progression in gliomas.
Cai C; Hu L; Wu K; Liu Y
PeerJ; 2024; 12():e17024. PubMed ID: 38638156
[TBL] [Abstract][Full Text] [Related]
5. A nuclear transport-related gene signature combined with IDH mutation and 1p/19q codeletion better predicts the prognosis of glioma patients.
Zhu Z; Lan Y; Wang L; Ge J; Wang J; Liu F; He Z; Zhang H; Luo M; Lin D; Tan Y; Xu Y; Luo T
BMC Cancer; 2020 Nov; 20(1):1072. PubMed ID: 33167941
[TBL] [Abstract][Full Text] [Related]
6. Systematically characterize the clinical and biological significances of 1p19q genes in 1p/19q non-codeletion glioma.
Chai RC; Zhang KN; Chang YZ; Wu F; Liu YQ; Zhao Z; Wang KY; Chang YH; Jiang T; Wang YZ
Carcinogenesis; 2019 Oct; 40(10):1229-1239. PubMed ID: 31157866
[TBL] [Abstract][Full Text] [Related]
7. RNA editing-based classification of diffuse gliomas: predicting isocitrate dehydrogenase mutation and chromosome 1p/19q codeletion.
Chen SC; Lo CM; Wang SH; Su EC
BMC Bioinformatics; 2019 Dec; 20(Suppl 19):659. PubMed ID: 31870275
[TBL] [Abstract][Full Text] [Related]
8. TERT promoter mutation confers favorable prognosis regardless of 1p/19q status in adult diffuse gliomas with IDH1/2 mutations.
Arita H; Matsushita Y; Machida R; Yamasaki K; Hata N; Ohno M; Yamaguchi S; Sasayama T; Tanaka S; Higuchi F; Iuchi T; Saito K; Kanamori M; Matsuda KI; Miyake Y; Tamura K; Tamai S; Nakamura T; Uda T; Okita Y; Fukai J; Sakamoto D; Hattori Y; Pareira ES; Hatae R; Ishi Y; Miyakita Y; Tanaka K; Takayanagi S; Otani R; Sakaida T; Kobayashi K; Saito R; Kurozumi K; Shofuda T; Nonaka M; Suzuki H; Shibuya M; Komori T; Sasaki H; Mizoguchi M; Kishima H; Nakada M; Sonoda Y; Tominaga T; Nagane M; Nishikawa R; Kanemura Y; Kuchiba A; Narita Y; Ichimura K
Acta Neuropathol Commun; 2020 Nov; 8(1):201. PubMed ID: 33228806
[TBL] [Abstract][Full Text] [Related]
9. 1p/19q co-deletion status is associated with distinct tumor-associated macrophage infiltration in IDH mutated lower-grade gliomas.
Zhang Y; Xie Y; He L; Tang J; He Q; Cao Q; Cui L; Guo W; Hua K; Dimberg A; Wang L; Zhang L
Cell Oncol (Dordr); 2021 Feb; 44(1):193-204. PubMed ID: 32915415
[TBL] [Abstract][Full Text] [Related]
10. GPR27 Regulates Hepatocellular Carcinoma Progression via MAPK/ERK Pathway.
Wang H; Du D; Huang J; Wang S; He X; Yuan S; Xiao J
Cancer Manag Res; 2022; 14():1165-1177. PubMed ID: 35330739
[TBL] [Abstract][Full Text] [Related]
11. Pediatric glioblastoma: mechanisms of immune evasion and potential therapeutic opportunities.
Njonkou R; Jackson CM; Woodworth GF; Hersh DS
Cancer Immunol Immunother; 2022 Aug; 71(8):1813-1822. PubMed ID: 35020009
[TBL] [Abstract][Full Text] [Related]
12. Glioma: molecular signature and crossroads with tumor microenvironment.
Barthel L; Hadamitzky M; Dammann P; Schedlowski M; Sure U; Thakur BK; Hetze S
Cancer Metastasis Rev; 2022 Mar; 41(1):53-75. PubMed ID: 34687436
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships of agonists for the orphan G protein-coupled receptor GPR27.
Pillaiyar T; Rosato F; Wozniak M; Blavier J; Charles M; Laschet C; Kronenberger T; Müller CE; Hanson J
Eur J Med Chem; 2021 Dec; 225():113777. PubMed ID: 34454125
[TBL] [Abstract][Full Text] [Related]
14. β-arrestin 2 stimulates degradation of HIF-1α and modulates tumor progression of glioblastoma.
Bae WY; Choi JS; Nam S; Jeong JW
Cell Death Differ; 2021 Nov; 28(11):3092-3104. PubMed ID: 34007068
[TBL] [Abstract][Full Text] [Related]
15. Deletion of Gpr27 in vivo reduces insulin mRNA but does not result in diabetes.
Chopra DG; Yiv N; Hennings TG; Zhang Y; Ku GM
Sci Rep; 2020 Mar; 10(1):5629. PubMed ID: 32221326
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
